Nuzhat Sharika, Abdullah Faisal, Islam Md Ridwan, Alam Baharul, Khan Azharul Islam, Chisti Mohammod Jobayer, Ahmed Tahmeed
Clinical and Diagnostic Services, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
Lancet Reg Health Southeast Asia. 2023 Dec 29;22:100344. doi: 10.1016/j.lansea.2023.100344. eCollection 2024 Mar.
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), which contains the world's largest diarrheal disease hospital, established a service centre, including testing facilities, isolation unit, out-patient department, in-patient ward, and intensive care unit during COVID-19 pandemic. When the management of COVID-19 was challenging nationwide, icddr,b established this facility with the goal to provide COVID-related services to the staff and their relatives amidst the pandemic. Data related to this analysis were collected from April 2020 to December 2021. 1399 patients received treatment under this facility. Among them, 351 patients were treated at the out-patient facility, 98 at the isolation, and 197 at the in-patient ward. Among the admitted patients, survival was 86.29% (n = 170/197). Among the suspected patients, 17% (n = 103/606) were COVID-positive. Setting up an immediate COVID-19 management facility during the pandemic was challenging. It can be an example of how an organisation can adapt to any emergency and act accordingly.
孟加拉国腹泻疾病研究国际中心（icddr，b）拥有世界上最大的腹泻疾病医院，在新冠疫情期间设立了一个服务中心，包括检测设施、隔离病房、门诊部、住院病房和重症监护室。当全国范围内的新冠疫情管理面临挑战时，icddr，b设立了这个设施，目的是在疫情期间为员工及其亲属提供与新冠相关的服务。本分析相关数据收集于2020年4月至2021年12月。有1399名患者在此设施接受治疗。其中，351名患者在门诊设施接受治疗，98名在隔离病房，197名在住院病房。在入院患者中，生存率为86.29%（n = 170/197）。在疑似患者中，17%（n = 103/606）新冠检测呈阳性。在疫情期间立即设立新冠疫情管理设施具有挑战性。这可以作为一个组织如何适应任何紧急情况并相应采取行动的例子。
